Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Orthopedic soft tissue repair devices market size to grow by USD 5,633.11 million from 2022 to 2027; The rising geriatric population across the globe will drive growth - Technavio


NEW YORK, March 24, 2023 /PRNewswire/ -- Technavio categorizes the global orthopedic soft tissue repair devices market size as estimated to increase by USD 5,633.11 million between 2022 and 2027. The market's growth momentum will be progressing at a CAGR of 11.05% during the forecast period. The growth of the market is driven by the rising geriatric population across the globe. In general, older adults heal more slowly than younger ones. Older people typically have low overall strength, flexibility, and balance compared to younger people. As a result, it is more challenging to make up for injury limitations and to resume daily activities. According to the Population Reference Bureau, by 2060, there will be 95 million Americans who are 65 years or older, up from an estimated 52 million in 2018. It is anticipated that the proportion of people 65 years and older will increase from 16% to 23%. As a result, there is a growing demand for both acute and long-term healthcare services, which is anticipated to drive the growth of the global orthopedic soft tissue repair devices market during the forecast period. Discover some insights on the market size historic period (2017 to 2021) and Forecast period (2023 to 2027) before buying the full report - Request a sample report

Global Orthopedic Soft Tissue Repair Devices Market - Segmentation Assessment
Segment Overview
Technavio has segmented the market based on product type (fixation devices, tissue scaffold, and cell therapy-based), and end-user (hospitals and clinics, ambulatory surgical centers, and physician's offices). 

Geography Overview
By geography, the global orthopedic soft tissue repair devices market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global orthopedic soft tissue repair devices market.

For insights on global, regional, and country-level parameters with growth opportunities from 2017 to 2027 - Download a Sample Report

Global Orthopedic soft tissue repair devices market ? Vendor Analysis
Vendor Landscape - The global orthopedic soft tissue repair devices market is fragmented, with the presence of several global as well as regional vendors. A few prominent vendors that offer orthopedic soft tissue repair devices in the market are Arthrex Inc., Becton Dickinson and Co., Boston Scientific Corp., Conmed Corp., Integra Lifesciences Holdings Corp., Johnson and Johnson, JRF Ortho, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, MTF Biologics, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, Wright Medical Group NV, Zimmer Biomet Holdings Inc., Acera Surgical Inc., AlloSource, and Amplitude Surgical and others.

A few prominent vendors that offer global orthopedic soft tissue repair devices in the market include:

What's New? -

Global Orthopedic Soft Tissue Repair Devices Market ? Market Dynamics

Key Trends - The growing use of orthopedic devices in emerging economies is a significant trend shaping growth. In the next few years, soft tissue repair products will become more widely used in emerging countries of Asia and ROW. Vendors are expected to witness many growth?opportunities in?such countries. This is due to the fact that the markets in these countries are experiencing a significant patent base for targeted indications (cardiovascular, orthopedics, general and gynecological diseases), rising health awareness, increasing healthcare spending,?and?growth in medical tourism. Also, medical procedures in these developing countries are less expensive compared to that in developed nations. Therefore, such factors are expected to drive the growth of the market in emerging economies, over the forecast period. 

Major challenges - The lack of availability of skilled personnel for the use of orthopedic soft tissue repair devices is a major challenge impeding the market growth. One of the major obstacles in the market is the shortage of qualified surgeons in both developed and developing countries. Technological developments in this field are rapidly changing the technology landscape and the areas in which soft tissue repair products are used. This requires physicians and other medical professionals to develop the skills necessary to use soft tissue repair products such as allografts, xenografts, and synthetic meshes. As a result, medical professionals in hospitals and clinics are reluctant to close wounds with cutting-edge surgical products. Therefore, factors like these will pose a major challenge to the growth of the global market during the forecast period. ? 

Drivers, Trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report! sample report!

What are the key data covered in this Orthopedic Soft Tissue Repair Devices Market report?

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports: 

Orthopedic Soft Tissue Repair Devices Market Scope

Report Coverage

Details

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 11.05%

Market growth 2023-2027

USD 5,633.11 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

10.58

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 45%

Key countries

US, Germany, France, UK, and Japan, Canada, Mexico, Italy,Spain, India, Japan, Australia,  and South Korea

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Arthrex Inc., Becton Dickinson and Co., Boston Scientific Corp., Conmed Corp., Integra Lifesciences Holdings Corp., Johnson and Johnson, JRF Ortho, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, MTF Biologics, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, Wright Medical Group NV, Zimmer Biomet Holdings Inc., Acera Surgical Inc., AlloSource, and Amplitude Surgical

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Product Type

7 Market Segmentation by End-user

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 16:10
Limoneira Company (the "Company" or "Limoneira") , a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, today reported financial results for the second...

at 16:05
ICF , a global consulting and technology services provider, was recently awarded a contract by the U.S. Department of Justice Office for Victims of Crime (OVC) to provide training and technical assistance (TTA) to better support and serve victims and...

at 15:50
Cue Health , a healthcare technology company, announces an industry breakthrough as the first company to receive De Novo authorization from the U.S. Food and Drug Administration (FDA) for its Cue COVID-19 Molecular Test, designed for both home and...

at 15:49
Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus...

at 15:35
Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Acuitas' LNP technology will support Bayer's in vivo gene...

at 14:45
The "Dental Floss Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War" report has been added to ResearchAndMarkets.com's offering. The global dental floss market is...



News published on and distributed by: